Cholesterol pill Muvalaplin, newly developed by US drug company Eli Lilly, has been shown to lower lipoprotein(a) — or Lp(a) — by 70% using regular blood tests and by 85.8% using a new blood test developed by the company called "intact lipoprotein(a) assay."
Study: Eli Lilly Pill Cuts Genetic High Cholesterol 86%